OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Global patterns of non‐Hodgkin lymphoma in 2020
Allini Mafra da Costa, Mathieu Laversanne, Mary Gospodarowicz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 9, pp. 1474-1481
Closed Access | Times Cited: 30
Allini Mafra da Costa, Mathieu Laversanne, Mary Gospodarowicz, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 9, pp. 1474-1481
Closed Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
Zanubrutinib: past, present, and future
Constantine S. Tam, Javier Muñoz, John F. Seymour, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Constantine S. Tam, Javier Muñoz, John F. Seymour, et al.
Blood Cancer Journal (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 22
Global burden, risk factors, and trends of non‐Hodgkin lymphoma: A worldwide analysis of cancer registries
Junjie Huang, Sze Chai Chan, Veeleah Lok, et al.
Cancer Medicine (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 8
Junjie Huang, Sze Chai Chan, Veeleah Lok, et al.
Cancer Medicine (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 8
Withanolides: Promising candidates for cancer therapy
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 7
Qiang Zhang, Yongkang Yuan, Shijie Cao, et al.
Phytotherapy Research (2024) Vol. 38, Iss. 2, pp. 1104-1158
Closed Access | Times Cited: 7
Risk of malignant lymphoma in patients with previous tuberculosis infection: a cohort study
Yun‐Gyoo Lee, Dong Min Seo, Hyun‐Il Gil, et al.
Annals of Hematology (2025)
Closed Access
Yun‐Gyoo Lee, Dong Min Seo, Hyun‐Il Gil, et al.
Annals of Hematology (2025)
Closed Access
Assessing the economic burden of Waldenström’s Macroglobulinemia (WM), Marginal Zone Lymphoma (MZL), and Chronic Lymphocytic Leukemia (CLL)
Matteo Scortichini, Martina Paoletti, Angela Ragonese, et al.
Global & Regional Health Technology Assessment (2025) Vol. 12, Iss. 1, pp. 80-88
Open Access
Matteo Scortichini, Martina Paoletti, Angela Ragonese, et al.
Global & Regional Health Technology Assessment (2025) Vol. 12, Iss. 1, pp. 80-88
Open Access
Graphene and its derivatives in medical applications: A comprehensive review
Farooq Ahmad, Huma Ghazal, Fazal Rasheed, et al.
Synthetic Metals (2024) Vol. 304, pp. 117594-117594
Closed Access | Times Cited: 4
Farooq Ahmad, Huma Ghazal, Fazal Rasheed, et al.
Synthetic Metals (2024) Vol. 304, pp. 117594-117594
Closed Access | Times Cited: 4
Analysis and prediction of relative survival trends in patients with non-Hodgkin lymphoma in the United States using a model-based period analysis method
Shuping Xie, Yu Zhong, Aozi Feng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Shuping Xie, Yu Zhong, Aozi Feng, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Autoimmune diseases and risk of non-Hodgkin lymphoma: A Mendelian randomisation study
Xiaoting Shi, Joshua D. Wallach, Xiaomei Ma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Xiaoting Shi, Joshua D. Wallach, Xiaomei Ma, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Valemetostat monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma: a first-in-human, multicentre, open-label, single-arm, phase 1 study
Dai Maruyama, Eric D. Jacobsen, Pierluigi Porcu, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. 1589-1601
Closed Access | Times Cited: 2
Dai Maruyama, Eric D. Jacobsen, Pierluigi Porcu, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 12, pp. 1589-1601
Closed Access | Times Cited: 2
Global view of haematolymphoid tumor classifications and their application in low‐ and middle‐income countries
Yuri Fedoriw, Oscar Silva, Ariana Znaor, et al.
Histopathology (2024)
Closed Access | Times Cited: 1
Yuri Fedoriw, Oscar Silva, Ariana Znaor, et al.
Histopathology (2024)
Closed Access | Times Cited: 1
Autoimmune Diseases and Risk of Non‐Hodgkin Lymphoma: A Mendelian Randomisation Study
Xiaoting Shi, Joshua D. Wallach, Xiaomei Ma, et al.
Cancer Medicine (2024) Vol. 13, Iss. 21
Open Access | Times Cited: 1
Xiaoting Shi, Joshua D. Wallach, Xiaomei Ma, et al.
Cancer Medicine (2024) Vol. 13, Iss. 21
Open Access | Times Cited: 1
Imaging evaluation of lymphoma in pregnancy with review of clinical assessment and treatment options
Kevin Dell’Aquila, Hannah Hodges, Mariam Moshiri, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 5, pp. 1663-1678
Open Access | Times Cited: 4
Kevin Dell’Aquila, Hannah Hodges, Mariam Moshiri, et al.
Abdominal Radiology (2023) Vol. 48, Iss. 5, pp. 1663-1678
Open Access | Times Cited: 4
Disturbed Plasma Lipidomic Profiles in Females with Diffuse Large B-Cell Lymphoma: A Pilot Study
Romana Masnikosa, David Pirić, Julia M. Post, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3653-3653
Open Access | Times Cited: 4
Romana Masnikosa, David Pirić, Julia M. Post, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3653-3653
Open Access | Times Cited: 4
Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma
Ginevra Farnetani, Matteo Vannucci, Maria Grazia Fino, et al.
Human Reproduction (2024) Vol. 39, Iss. 3, pp. 496-503
Closed Access | Times Cited: 1
Ginevra Farnetani, Matteo Vannucci, Maria Grazia Fino, et al.
Human Reproduction (2024) Vol. 39, Iss. 3, pp. 496-503
Closed Access | Times Cited: 1
Assessment of Clinical and Diagnostic Indicators of Cardiovascular Toxicity in Patients with Non-Hodgkin’s Lymphomas in the Course of Programmatic Antitumor Therapy
G. R. Gimatdinova, О. Е. Данилова, И. Л. Давыдкин, et al.
The Russian Archives of Internal Medicine (2024) Vol. 14, Iss. 2, pp. 144-153
Open Access | Times Cited: 1
G. R. Gimatdinova, О. Е. Данилова, И. Л. Давыдкин, et al.
The Russian Archives of Internal Medicine (2024) Vol. 14, Iss. 2, pp. 144-153
Open Access | Times Cited: 1
HK2 contributes to the proliferation, migration, and invasion of diffuse large B-cell lymphoma cells by enhancing the ERK1/2 signaling pathway
Hongcan Zhao, Guoqian Xiang, Tingjun Shao, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Hongcan Zhao, Guoqian Xiang, Tingjun Shao, et al.
Open Life Sciences (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 3
Guideline Concordance of Treatment and Outcomes Among Adult Non-Hodgkin Lymphoma Patients in Sub-Saharan Africa: A Multinational, Population-Based Cohort
Nikolaus Christian Simon Mezger, Lucia Hämmerl, Mirko Griesel, et al.
The Oncologist (2023) Vol. 28, Iss. 11, pp. e1017-e1030
Open Access | Times Cited: 2
Nikolaus Christian Simon Mezger, Lucia Hämmerl, Mirko Griesel, et al.
The Oncologist (2023) Vol. 28, Iss. 11, pp. e1017-e1030
Open Access | Times Cited: 2
A Novel Public Database of Lymphoma for Whole Body Diffusion-Weighted MRI
Radhia Ferjaoui, Sana Boujnah, Nour El Houda Kraiem, et al.
(2023), pp. 209-216
Closed Access | Times Cited: 2
Radhia Ferjaoui, Sana Boujnah, Nour El Houda Kraiem, et al.
(2023), pp. 209-216
Closed Access | Times Cited: 2
Insights into the molecular mechanisms of H. pylori -associated B-cell lymphoma
Kritika Malik, Prashant Kodgire
Critical Reviews in Microbiology (2024) Vol. 50, Iss. 5, pp. 879-895
Closed Access
Kritika Malik, Prashant Kodgire
Critical Reviews in Microbiology (2024) Vol. 50, Iss. 5, pp. 879-895
Closed Access
Incidence and survival of second primary non-Hodgkin lymphoma: A Surveillance, Epidemiology, and End Results-based cohort study
Nasha Yu, Weimin Zhang, Xing Zhong, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300330-e0300330
Open Access
Nasha Yu, Weimin Zhang, Xing Zhong, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0300330-e0300330
Open Access
NGHIÊN CỨU TỔNG QUAN CÁC TÁC DỤNG KHÔNG MONG MUỐN Ở BỆNH NHÂN HÓA TRỊ THEO PHÁC ĐỒ R-CHOP TRONG U LYMPHO KHÔNG HODGKIN VÙNG ĐẦU CỔ
Anh Sỹ Quế Phan, Thị Bích Đào Phạm
Tạp chí Y học Việt Nam (2024) Vol. 537, Iss. 2
Open Access
Anh Sỹ Quế Phan, Thị Bích Đào Phạm
Tạp chí Y học Việt Nam (2024) Vol. 537, Iss. 2
Open Access
The causality between gut microbiota and non-Hodgkin lymphoma: a two-sample bidirectional Mendelian randomization study
Jinjie Fu, Hao Zheng
Frontiers in Microbiology (2024) Vol. 15
Open Access
Jinjie Fu, Hao Zheng
Frontiers in Microbiology (2024) Vol. 15
Open Access
Non-Hodgkin lymphoma incidence, mortality, and survival trends in Brunei Darussalam from 2011 to 2020
Mwalim Kombo Mwalim, Elvynna Leong, Sok King Ong, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Mwalim Kombo Mwalim, Elvynna Leong, Sok King Ong, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas
Xiaoping Zhang, Yang Li, Mengchen Zhu, et al.
Future Oncology (2024), pp. 1-11
Closed Access
Xiaoping Zhang, Yang Li, Mengchen Zhu, et al.
Future Oncology (2024), pp. 1-11
Closed Access
Causal pathways in Lymphoma: The role of serum metabolites and immune cells determined by Mendelian randomization
Xin Zhuang, Xia Zhang, Qingning Yin, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113593-113593
Open Access
Xin Zhuang, Xia Zhang, Qingning Yin, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113593-113593
Open Access
